Organization: Aquinox Pharmaceuticals Inc

BIOTECanada announces 2012 Gold Leaf Awards

BIOTECanada has announced the winners of its 2013 Gold Leaf Awards. The announcement was made April 23rd at the BIO International Convention in Chicago.The winners are: Xenon Pharmaceuticals Inc (Company of the Year); Dr Albert Friesen (Industry Leadership); Novo Nordisk; (Contribution to Canadian Communities); Aquinox Pharmaceuticals Inc (Early Stage Health); Okanagan Specialty Fruits Inc (Early…

Aquinox completes US$14.5 million financing

Vancouver-based Aquinox Pharmaceuticals Inc has completed a US$14.5-million series ‘A’ financing to further develop targeted small molecules therapeutics based on its proprietary SH2-containing inosital phosphatase biochemical enzyme. The enzyme regulates the PI3K pathway for regulating cell growth and survival and immune cell regulation. Aquinox is a spin-off from the Univ of British Columbia and BC…